SCHEMBL13085162

SCHEMBL13085162

C=C(NCc1ccccc1)C(c1ccccc1)C1CCN(c2ccc(NC(=O)c3ccccc3-c3ccc(Cl)cc3)cc2)CC1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ NPY2R P49146 9/20 0.49
▸ MTTP P55157 5/20 0.49
▸ EP300 Q09472 2/20 0.41
▸ MAPT P10636 2/20 0.41
▸ MAPK1 P28482 2/20 0.41
▸ TSHR P16473 1/20 0.41
▸ CHRNB2 P17787 1/20 0.41
▸ CHRNB4 P30926 1/20 0.41
▸ CHRNA3 P32297 1/20 0.41
▸ CHRNA4 P43681 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ FPR2 P25090 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12174411 0.92 NPY2R (0.56) NPY2RMTTPEP300MAPTMAPK1
SCHEMBL13085083 0.90 MTTP (0.49) NPY2RMTTP
SCHEMBL13085101 0.87 NPY2R (0.46) NPY2RMTTPMAPTMAPK1TSHR
SCHEMBL12174527 0.85 NPY2R (0.62) NPY2RMTTPMAPTMAPK1TSHR
SCHEMBL12174537 0.85 NPY2R (0.67) NPY2RMTTPEP300ALDH1A1
SCHEMBL12174526 0.84 NPY2R (0.54) NPY2RMTTPEP300MAPTMAPK1
SCHEMBL12174461 0.84 NPY2R (0.55) NPY2RMTTPMAPTMAPK1TSHR
SCHEMBL13085189 0.84 NPY2R (0.55) NPY2RMTTPMAPTMAPK1TSHR
SCHEMBL12174506 0.83 NPY2R (0.58) NPY2RMTTPEP300MAPTMAPK1
SCHEMBL12174544 0.83 NPY2R (0.60) NPY2RMTTPMAPTMAPK1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1317431-B1 POLYARYLCARBOXAMIDES USEFUL AS LIPID LOWERING AGENTS JANSSEN PHARMACEUTICA NV (BE) 2010-10-20 — — EP disclosed
Send feedback